These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12820143

  • 21. [A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].
    Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ.
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):323-6. PubMed ID: 16732903
    [Abstract] [Full Text] [Related]

  • 22. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy.
    Akyuz F, Kaymakoglu S, Demir K, Aksoy N, Karaca C, Danalioglu A, Onel D, Badur S, Besisik F, Cakaloglu Y, Okten A.
    Acta Gastroenterol Belg; 2007 May; 70(1):20-4. PubMed ID: 17619534
    [Abstract] [Full Text] [Related]

  • 23. [Clinical trial of sequential antiviral therapy for patients with chronic hepatitis B in China].
    Lei CL, Peng XM, Tang XP, Yang Z, Fan HM, Yuan XZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):69-72. PubMed ID: 15340532
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 25. [Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].
    Lu HY, Zhuang LW, Yu YY, Si CW, Li J.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):198-202. PubMed ID: 18364079
    [Abstract] [Full Text] [Related]

  • 26. Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B.
    Economou M, Manolakopoulos S, Trikalinos TA, Filis S, Bethanis S, Tzourmakliotis D, Avgerinos A, Raptis S, Tsianos EV.
    World J Gastroenterol; 2005 Oct 07; 11(37):5882-7. PubMed ID: 16270403
    [Abstract] [Full Text] [Related]

  • 27. [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].
    Mao HY, Shi TD.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan 07; 19(1):29-33. PubMed ID: 21272455
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparison of lamivudine or interferon monotherapy and sequential therapy in chronic hepatitis B: a random controlled trial].
    Xu JH, Yu YY, Si CW, Chen XY, Han ZH, Chen Y, Zhang WJ, Xu DZ, Chen YP, Yu M, Xi HL, Li XY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec 18; 42(6):739-45. PubMed ID: 21170108
    [Abstract] [Full Text] [Related]

  • 33. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
    Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Brunetto MR, Farci P, Popescu M, McCloud P, Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group.
    Gut; 2007 May 18; 56(5):699-705. PubMed ID: 17127704
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH, Deng X, Chen XC, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 18; 21(1):62-3. PubMed ID: 17429539
    [Abstract] [Full Text] [Related]

  • 36. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 37. Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations.
    Shi M, Wang RS, Zhang H, Zhu YF, Han B, Zhang Y, Jin LJ, Yang ZJ, Xu YP.
    J Antimicrob Chemother; 2006 Nov 10; 58(5):1031-5. PubMed ID: 16987866
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic vaccination in chronic hepatitis B.
    Senturk H, Tabak F, Akdogan M, Erdem L, Mert A, Ozaras R, Sander E, Ozbay G, Badur S.
    J Gastroenterol Hepatol; 2002 Jan 10; 17(1):72-6. PubMed ID: 11895556
    [Abstract] [Full Text] [Related]

  • 39. Randomized trial of lamivudine, adefovir, and the combination in HBeAg-positive chronic hepatitis B.
    He Z, Wang J, Liu K, Huang H, Du Y, Lin Z, Cai M, Feng X.
    Clin Res Hepatol Gastroenterol; 2012 Dec 10; 36(6):592-7. PubMed ID: 23069315
    [Abstract] [Full Text] [Related]

  • 40. Treatment of chronic hepatitis B with the sequential administration of interferon and lamivudine.
    Hasan F, al-Khaldi J, Asker H, Varghese R, Siddique I, al-Shammali M, al-Kalaoui M, al-Nakib B.
    Hepatogastroenterology; 2003 Dec 10; 50(54):2040-2. PubMed ID: 14696461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.